{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:21:07Z","timestamp":1791865267729,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1772,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1038\/mt.2011.219","type":"journal-article","created":{"date-parts":[[2011,10,26]],"date-time":"2011-10-26T17:11:14Z","timestamp":1319649074000},"page":"2152-2162","source":"Crossref","is-referenced-by-count":233,"title":["Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease"],"prefix":"10.1016","volume":"19","author":[{"given":"Jodi L","family":"McBride","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Pitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan L","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio R","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly L","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2011.219_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"Huntington Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1038\/mt.2011.219_bib2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2011.219_bib3","first-page":"235","article-title":"Role of basal ganglia in limb movements","volume":"2","author":"DeLong","year":"1984","journal-title":"Hum Neurobiol"},{"key":"10.1038\/mt.2011.219_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/cne.903040406","article-title":"Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque","volume":"304","author":"Hedreen","year":"1991","journal-title":"J Comp Neurol"},{"key":"10.1038\/mt.2011.219_bib5","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1523\/JNEUROSCI.17-10-03870.1997","article-title":"Differential activation of the caudate nucleus in primates performing spatial and nonspatial working memory tasks","volume":"17","author":"Levy","year":"1997","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2011.219_bib6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archneur.1988.00520310079021","article-title":"Presymptomatic neuropsychological impairment in Huntington's disease","volume":"45","author":"Jason","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1038\/mt.2011.219_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(01)02326-6","article-title":"Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model","volume":"315","author":"Schilling","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1038\/mt.2011.219_bib8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mds.10229","article-title":"Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease","volume":"17","author":"Schiefer","year":"2002","journal-title":"Mov Disord"},{"key":"10.1038\/mt.2011.219_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1523\/JNEUROSCI.18-01-00156.1998","article-title":"Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease","volume":"18","author":"Matthews","year":"1998","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2011.219_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2004.09.017","article-title":"Minocycline in phenotypic models of Huntington's disease","volume":"18","author":"Bantubungi","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2011.219_bib11","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1073\/pnas.83.8.2728","article-title":"Graft-induced behavioral recovery in an animal model of Huntington disease","volume":"83","author":"Isacson","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.219_bib12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mt.2011.219_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(04)00678-7","article-title":"Molecular medicine for the brain: silencing of disease genes with RNA interference","volume":"3","author":"Davidson","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1038\/mt.2011.219_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/hum.2006.160","article-title":"High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo","volume":"18","author":"Huang","year":"2007","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2011.219_bib15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2008.50","article-title":"AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease","volume":"16","author":"Franich","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.219_bib16","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.219_bib17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr Biol"},{"key":"10.1038\/mt.2011.219_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2011.219_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(03)00569-5","article-title":"Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport","volume":"40","author":"Szebenyi","year":"2003","journal-title":"Neuron"},{"key":"10.1038\/mt.2011.219_bib20","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.219_bib21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.219_bib22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1038\/mt.2011.219_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1038\/mt.2011.219_bib24","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1261\/rna.1062908","article-title":"Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs","volume":"14","author":"Boudreau","year":"2008","journal-title":"RNA"},{"key":"10.1038\/mt.2011.219_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0197-4580(91)90048-O","article-title":"Aged monkeys exhibit behavioral deficits indicative of widespread cerebral dysfunction","volume":"12","author":"Bachevalier","year":"1991","journal-title":"Neurobiol Aging"},{"key":"10.1038\/mt.2011.219_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0165-0270(99)00051-5","article-title":"An automated movement assessment panel for upper limb motor functions in rhesus monkeys and humans","volume":"89","author":"Gash","year":"1999","journal-title":"J Neurosci Methods"},{"key":"10.1038\/mt.2011.219_bib27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0306-4522(94)00431-4","article-title":"Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease","volume":"64","author":"Burns","year":"1995","journal-title":"Neuroscience"},{"key":"10.1038\/mt.2011.219_bib28","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","article-title":"Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates","volume":"15","author":"Palfi","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.219_bib29","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/hmg\/ddg305","article-title":"Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum","volume":"12","author":"R\u00e9gulier","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2011.219_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1750-3639.2001.tb00378.x","article-title":"Differential recruitment of CD8+ macrophages during Wallerian degeneration in the peripheral and central nervous system","volume":"11","author":"Jander","year":"2001","journal-title":"Brain Pathol"},{"key":"10.1038\/mt.2011.219_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-4886(90)90014-J","article-title":"A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon","volume":"108","author":"Hantraye","year":"1990","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2011.219_bib32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.7679223","article-title":"Multiple output channels in the basal ganglia","volume":"259","author":"Hoover","year":"1993","journal-title":"Science"},{"key":"10.1038\/mt.2011.219_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1523\/JNEUROSCI.05-03-00776.1985","article-title":"Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey","volume":"5","author":"Selemon","year":"1985","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2011.219_bib34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ana.410440319","article-title":"Somatotopical organization of striatal activation during finger and toe movement: a 3-T functional magnetic resonance imaging study","volume":"44","author":"Leh\u00e9ricy","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1038\/mt.2011.219_bib35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1212\/WNL.55.3.377","article-title":"Mapping the basal ganglia: fMRI evidence for somatotopic representation of face, hand, and foot","volume":"55","author":"Maillard","year":"2000","journal-title":"Neurology"},{"key":"10.1038\/mt.2011.219_bib36","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1097\/00001756-200410250-00005","article-title":"Distinct striatal regions support movement selection, preparation and execution","volume":"15","author":"Gerardin","year":"2004","journal-title":"Neuroreport"},{"key":"10.1038\/mt.2011.219_bib37","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/hmg\/ddl252","article-title":"Cholinergic neuronal defect without cell loss in Huntington's disease","volume":"15","author":"Smith","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2011.219_bib38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/mt.2009.216","article-title":"Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates","volume":"18","author":"Dodiya","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.219_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/hum.2008.151","article-title":"Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response","volume":"20","author":"Hadaczek","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2011.219_bib40","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","article-title":"Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice","volume":"285","author":"Bradford","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2011.219_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jgm.885","article-title":"Immune responses to AAV in a phase I study for Canavan disease","volume":"8","author":"McPhee","year":"2006","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2011.219_bib42","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"key":"10.1038\/mt.2011.219_bib43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/mt.2009.277","article-title":"Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration","volume":"18","author":"Simonelli","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.219_bib44","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates","volume":"19","author":"Gray","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.219_bib45","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/JVI.74.5.2420-2425.2000","article-title":"Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle","volume":"74","author":"Chirmule","year":"2000","journal-title":"J Virol"},{"key":"10.1038\/mt.2011.219_bib46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2011.219_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/mt.2011.185","article-title":"Rational design of therapeutic siRNA: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease","author":"Boudreau","year":"2011","journal-title":"Mol. Ther"},{"key":"10.1038\/mt.2011.219_bib48","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/mt.2009.128","article-title":"A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells","volume":"17","author":"Smith","year":"2009","journal-title":"Mol Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616327009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616327009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T16:39:34Z","timestamp":1560875974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616327009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1525001616327009"],"URL":"https:\/\/doi.org\/10.1038\/mt.2011.219","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}